http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2009132951-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-36 |
| filingDate | 2008-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2009132951-A |
| titleOfInvention | APPLICATION OF ARSENIC COMPOUNDS FOR TREATMENT OF PAIN AND INFLAMMATION |
| abstract | 1. The use of arsenic compounds selected from sodium meta arsenite, arsenic trioxide and / or arsenic hexoxide in the manufacture of a pharmaceutical composition for treating pain in a mammal. ! 2. The use according to claim 1, in which the pain is visceral pain, pain associated with cancer, post-surgical pain, central pain, chronic pain or spinal pain. ! 3. The use according to claim 1, in which the arsenic compound is sodium meta arsenite. ! 4. The use according to claim 1, wherein the arsenic compound is arsenic trioxide. ! 5. The use according to claim 1, wherein the arsenic compound is a combination of sodium meta arsenite and arsenic trioxide. ! 6. The use according to claim 3, in which the pharmaceutical composition is formulated for oral administration. ! 7. The use according to claim 1, wherein the pharmaceutical composition comprises a dosage amount of an arsenic compound from about 0.5 mg / kg to about 70 mg / kg. ! 8. The use according to claim 1, wherein the pharmaceutical composition comprises a dosage amount of an arsenic compound from about 10 mg / kg to about 30 mg / kg. ! 9. The use of a compound of arsenic selected from sodium meta arsenite, arsenic trioxide and / or arsenic hexoxide in the manufacture of a pharmaceutical composition for treating inflammation in a mammal. ! 10. The use according to claim 9, in which the inflammation is associated with asthma. ! 11. The use according to claim 9, in which the inflammation is associated with a pulmonary disease. ! 12. The use according to claim 9, in which the inflammation is associated with an autoimmune disease. ! 13. The use of claim 9, wherein the inflammation is associated with arthritis. ! 14. The use according to claim 9, in which the pharmaceutical composition |
| priorityDate | 2007-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 32.